Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center




A Phase 2, Open-Label, Study Evaluating Safety and Efficacy of the Loncastuximab in Relapsed/Refractory Marginal Zone Lymphoma

Lymphoma

Lymphoma
II
Oluwole, Olalekan
NCT05296070
VICC-ITCTT23024

Study Evaluating 89ZrPanitumumab for Assessment of Indeterminate Metastatic and/or Primary Lesion(s) on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma

Head/Neck

Head/Neck
I
Topf, Michael
NCT05747625
VICCHN2279

Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Neuroblastoma (Pediatrics)

Neuroblastoma (Pediatrics)
II
Benedetti, Daniel
NCT06540963
VICCPED24540

A Randomized Clinical Trial Comparing ctDNA-directed Therapy Change with Standard of Care in Patients with Metastatic Triple Negative Breast Cancer

Breast

Breast
II
Abramson, Vandana
NCT05770531
VICCBRE2257



A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-Alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors

Multiple Cancer Types

Breast, Cervical, Gastrointestinal, Gynecologic, Head/Neck, Lung, Phase I, Urologic
I
Abramson, Vandana
NCT05683418
VICC-DTPHI23103


Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.